Differences in purinergic amplification of osmotic cell lysis by the pore-forming RTX toxins bordetella pertussis CyaA and actinobacillus pleuropneumoniae ApxIA: The role of pore size

Infection and Immunity

Volumn 81, Issue 12, 2013, Pages 4571-4582

  Masin, Jiri ^a   Fiser, Radovan ^a,b   Linhartova, Irena ^a   Osicka, Radim ^a   Bumba, Ladislav ^a   Hewlett, Erik L ^c   Benz, Roland ^d,e   Sebo, Peter ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e JACOBS UNIVERSITY BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOBACILLUS PLEUROPNEUMONIAE APXIA TOXIN; BACTERIAL TOXIN; BORDETELLA PERTUSSIS CYAA TOXIN; BRILLIANT BLUE; CALCIUM CHANNEL; HEMOLYSIN; HEXOKINASE; PERTUSSIS TOXIN; PORE FORMING CYTOTOXIC PROTEIN; POTASSIUM CHANNEL; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SODIUM; UNCLASSIFIED DRUG;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL CELL; ARTICLE; BORDETELLA PERTUSSIS; CELL MEMBRANE PERMEABILITY; CELL SWELLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEMOLYSIS; LIPID BILAYER; MOUSE; NONHUMAN; OSMOTIC CELL LYSIS; POROSITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACTINOBACILLUS PLEUROPNEUMONIAE; ADENYLATE CYCLASE TOXIN; ANIMALS; BACTERIAL PROTEINS; BORDETELLA PERTUSSIS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; ERYTHROCYTES; HEMOLYSIN PROTEINS; HEMOLYSIS; HEXOKINASE; LIPID BILAYERS; MACROPHAGES; MICE; OSMOTIC PRESSURE; PYRIDOXAL PHOSPHATE; ROSANILINE DYES;

EID: 84890145657     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00711-13     Document Type: Article

References (79)

1. Linhartova I, Bumba L, Masin J, Basler M, Osicka R, Kamanova J, Prochazkova K, Adkins I, Hejnova-Holubova J, Sadilkova L, Morova J, Sebo P. 2010. RTX proteins: a highly diverse family secreted by a common mechanism. FEMS Microbiol. Rev. 34:1076-1112.
2. Goebel W, Hedgpeth J. 1982. Cloning and functional characterization of the plasmid-encoded hemolysin determinant of Escherichia coli. J. Bacteriol. 151:1290-1298.
3. Welch RA. 1991. Pore-forming cytolysins of gram-negative bacteria. Mol. Microbiol. 5:521-528.
4. Benz R, Maier E, Ladant D, Ullmann A, Sebo P. 1994. Adenylate cyclase toxin (CyaA) of Bordetella pertussis. Evidence for the formation of small ion-permeable channels and comparison with HlyA of Escherichia coli. J. Biol. Chem. 269:27231-27239.
5. Benz R, Schmid A, Wagner W, Goebel W. 1989. Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates. Infect. Immun. 57:887-895.
6. Maier E, Reinhard N, Benz R, Frey J. 1996. Channel-forming activity and channel size of the RTX toxins ApxI, ApxII, and ApxIII of Actinobacillus pleuropneumoniae. Infect. Immun. 64:4415-4423.
7. Szabo G, Gray MC, Hewlett EL. 1994. Adenylate cyclase toxin from Bordetella pertussis produces ion conductance across artificial lipid bilayers in a calcium- and polarity-dependent manner. J. Biol. Chem. 269:22496-22499.
8. Goodwin MS, Weiss AA. 1990. Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice. Infect. Immun. 58:3445-3447.
9. Khelef N, Sakamoto H, Guiso N. 1992. Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Microb. Pathog. 12:227-235.
10. Weiss AA, Hewlett EL, Myers GA, Falkow S. 1983. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect. Immun. 42:33-41.
11. Glaser P, Ladant D, Sezer O, Pichot F, Ullmann A, Danchin A. 1988. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol. Microbiol. 2:19-30.
12. Glaser P, Sakamoto H, Bellalou J, Ullmann A, Danchin A. 1988. Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclasehaemolysin bifunctional protein of Bordetella pertussis. EMBO J. 7:3997-4004.
13. Bellalou J, Sakamoto H, Ladant D, Geoffroy C, Ullmann A. 1990. Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase. Infect. Immun. 58:3242-3247.
14. Fiser R, Masin J, Bumba L, Pospisilova E, Fayolle C, Basler M, Sadilkova L, Adkins I, Kamanova J, Cerny J, Konopasek I, Osicka R, Leclerc C, Sebo P. 2012. Calcium influx rescues adenylate cyclasehemolysin from rapid cell membrane removal and enables phagocyte permeabilization by toxin pores. PLoS Pathog. 8:e1002580. doi:10.1371/journal.ppat.1002580.
15. + efflux, intoxication, and hemolysis by Bordetella pertussis AC toxin. J. Biol. Chem. 273:18260-18267.
16. Osickova A, Masin J, Fayolle C, Krusek J, Basler M, Pospisilova E, Leclerc C, Osicka R, Sebo P. 2010. Adenylate cyclase toxin translocates across target cell membrane without forming a pore. Mol. Microbiol. 75:1550-1562.
17. Basler M, Masin J, Osicka R, Sebo P. 2006. Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes. Infect. Immun. 74:2207-2214.
18. Hewlett EL, Donato GM, Gray MC. 2006. Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP! Mol. Microbiol. 59:447-459.
19. Barry EM, Weiss AA, Ehrmann IE, Gray MC, Hewlett EL, Goodwin MS. 1991. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J. Bacteriol. 173:720-726.
20. Basar T, Havlicek V, Bezouskova S, Hackett M, Sebo P. 2001. Acylation of lysine 983 is sufficient for toxin activity of Bordetella pertussis adenylate cyclase. Substitutions of alanine 140 modulate acylation site selectivity of the toxin acyltransferase CyaC. J. Biol. Chem. 276:348-354.
21. Basar T, Havlicek V, Bezouskova S, Halada P, Hackett M, Sebo P. 1999. The conserved lysine 860 in the additional fatty-acylation site of Bordetella pertussis adenylate cyclase is crucial for toxin function independently of its acylation status. J. Biol. Chem. 274:10777-10783.
22. Hackett M, Guo L, Shabanowitz J, Hunt DF, Hewlett EL. 1994. Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science 266:433-435.
23. Hackett M, Walker CB, Guo L, Gray MC, Van Cuyk S, Ullmann A, Shabanowitz J, Hunt DF, Hewlett EL, Sebo P. 1995. Hemolytic, but not cell-invasive activity, of adenylate cyclase toxin is selectively affected by differential fatty-acylation in Escherichia coli. J. Biol. Chem. 270:20250-20253.
24. Masin J, Basler M, Knapp O, El-Azami-El-Idrissi M, Maier E, Konopasek I, Benz R, Leclerc C, Sebo P. 2005. Acylation of lysine 860 allows tight binding and cytotoxicity of Bordetella adenylate cyclase on CD11b-expressing cells. Biochemistry 44:12759-12766.
25. Baumann U, Wu S, Flaherty KM, McKay DB. 1993. Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a twodomain protein with a calcium binding parallel beta roll motif. EMBO J. 12:3357-3364.
26. Knapp O, Maier E, Polleichtner G, Masin J, Sebo P, Benz R. 2003. Channel formation in model membranes by the adenylate cyclase toxin of Bordetella pertussis: effect of calcium. Biochemistry 42:8077-8084.
27. Rose T, Sebo P, Bellalou J, Ladant D. 1995. Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes. J. Biol. Chem. 270:26370-26376.
28. Osickova A, Osicka R, Maier E, Benz R, Sebo P. 1999. An amphipathic alpha-helix including glutamates 509 and 516 is crucial for membrane translocation of adenylate cyclase toxin and modulates formation and cation selectivity of its membrane channels. J. Biol. Chem. 274:37644-37650.
29. Vojtova-Vodolanova J, Basler M, Osicka R, Knapp O, Maier E, Cerny J, Benada O, Benz R, Sebo P. 2009. Oligomerization is involved in pore formation by Bordetella adenylate cyclase toxin. FASEB J. 23:2831-2843.
30. Basler M, Knapp O, Masin J, Fiser R, Maier E, Benz R, Sebo P, Osicka R. 2007. Segments crucial for membrane translocation and pore-forming activity of Bordetella adenylate cyclase toxin. J. Biol. Chem. 282:12419-12429.
31. Havlicek V, Higgins L, Chen W, Halada P, Sebo P, Sakamoto H, Hackett M. 2001. Mass spectrometric analysis of recombinant adenylate cyclase toxin from Bordetella pertussis strain 18323/pHSP9. J. Mass Spectrom. 36:384-391.
32. Ehrmann IE, Gray MC, Gordon VM, Gray LS, Hewlett EL. 1991. Hemolytic activity of adenylate cyclase toxin from Bordetella pertussis. FEBS Lett. 278:79-83.
33. Shope RE, White DC, Leidy G. 1964. Porcine contagious pleuropneumonia. II. Studies of the pathogenicity of the etiological agent, Hemophilus pleuropneumoniae. J. Exp. Med. 119:369-375.
34. Frey J, Meier R, Gygi D, Nicolet J. 1991. Nucleotide sequence of the hemolysin I gene from Actinobacillus pleuropneumoniae. Infect. Immun. 59:3026-3032.
35. Frey J, Nicolet J. 1990. Hemolysin patterns of Actinobacillus pleuropneumoniae. J. Clin. Microbiol. 28:232-236.
36. Rosendal S, Devenish J, MacInnes JI, Lumsden JH, Watson S, Xun H. 1988. Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic activity of Haemophilus (Actinobacillus) pleuropneumoniae. Am. J. Vet. Res. 49:1053-1058.
37. Munksgaard PS, Vorup-Jensen T, Reinholdt J, Soderstrom CM, Poulsen K, Leipziger J, Praetorius HA, Skals M. 2012. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes. Cell. Microbiol. 14:1904-1920.
38. Skals M, Jorgensen NR, Leipziger J, Praetorius HA. 2009. Alphahemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc. Natl. Acad. Sci. U. S. A. 106:4030-4035.
39. Fagerberg SK, Skals M, Leipziger J, Praetorius HA. 2013. P2X receptordependent erythrocyte damage by alpha-hemolysin from Escherichia coli triggers phagocytosis by THP-1 cells. Toxins (Basel) 5:472-487.
40. Skals M, Leipziger J, Praetorius HA. 2011. Haemolysis induced by alphatoxin from Staphylococcus aureus requires P2X receptor activation. Pflugers Arch. 462:669-679.
41. Kelk P, Abd H, Claesson R, Sandstrom G, Sjostedt A, Johansson A. 2011. Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin. Cell Death Dis. 2:e126. doi:10.1038/cddis.2011.6.
42. Bao L, Locovei S, Dahl G. 2004. Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett. 572:65-68.
43. Pelegrin P, Surprenant A. 2009. The P2X(7) receptor-pannexin connection to dye uptake and IL-1beta release. Purinergic Signal. 5:129-137.
44. Di Virgilio F. 1995. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today 16:524-528.
45. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735-738.
46. Miller CM, Boulter NR, Fuller SJ, Zakrzewski AM, Lees MP, Saunders BM, Wiley JS, Smith NC. 2011. The role of the P2X(7) receptor in infectious diseases. PLoS Pathog. 7:e1002212. doi:10.1371/journal.ppat.1002212.
47. Osicka R, Osickova A, Basar T, Guermonprez P, Rojas M, Leclerc C, Sebo P. 2000. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Infect. Immun. 68:247-256.
48. Gray MC, Lee SJ, Gray LS, Zaretzky FR, Otero AS, Szabo G, Hewlett EL. 2001. Translocation-specific conformation of adenylate cyclase toxin from Bordetella pertussis inhibits toxin-mediated hemolysis. J. Bacteriol. 183:5904-5910.
49. Betsou F, Sebo P, Guiso N. 1993. CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin. Infect. Immun. 61:3583-3589.
50. Sadilkova L, Nepereny J, Vrzal V, Sebo P, Osicka R. 2012. Type IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia. Vet. Res. 43:2. doi:10.1186/1297-9716-43-2.
51. Ladant D. 1988. Interaction of Bordetella pertussis adenylate cyclase with calmodulin. Identification of two separated calmodulin-binding domains. J. Biol. Chem. 263:2612-2618.
52. Iwaki M, Ullmann A, Sebo P. 1995. Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin. Mol. Microbiol. 17:1015-1024.
53. Lee SJ, Gray MC, Guo L, Sebo P, Hewlett EL. 1999. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Infect. Immun. 67:2090-2095.
54. Moayeri M, Welch RA. 1994. Effects of temperature, time, and toxin concentration on lesion formation by the Escherichia coli hemolysin. Infect. Immun. 62:4124-4134.
55. Harris RW, Sims PJ, Tweten RK. 1991. Evidence that Clostridium perfringens theta-toxin induces colloid-osmotic lysis of erythrocytes. Infect. Immun. 59:2499-2501.
56. North RA. 2002. Molecular physiology of P2X receptors. Physiol. Rev. 82:1013-1067.
57. Karst JC, Barker R, Devi U, Swann MJ, Davi M, Roser SJ, Ladant D, Chenal A. 2012. Identification of a region that assists membrane insertion and translocation of the catalytic domain of Bordetella pertussis CyaA toxin. J. Biol. Chem. 287:9200-9212.
58. Beis I, Newsholme EA. 1975. The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem. J. 152:23-32.
59. Bhakdi S, Mackman N, Nicaud JM, Holland IB. 1986. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect. Immun. 52:63-69.
60. Bhakdi S, Tranum-Jensen J. 1991. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55:733-751.
61. Gerard C, Boudier JA, Mauchamp J, Verrier B. 1990. Evidence for probenecid-sensitive organic anion transporters on polarized thyroid cells in culture. J. Cell. Physiol. 144:354-364.
62. Hsyu PH, Gisclon LG, Hui AC, Giacomini KM. 1988. Interactions of organic anions with the organic cation transporter in renal BBMV. Am. J. Physiol. 254:F56-F61.
63. Perwitasari O, Yan X, Johnson S, White C, Brooks P, Tompkins SM, Tripp RA. 2013. Targeting organic anion transporter 3 with probenecid as a novel anti-influenza A virus strategy. Antimicrob. Agents Chemother. 57:475-483.
64. Tovar KR, Maher BJ, Westbrook GL. 2009. Direct actions of carbenoxolone on synaptic transmission and neuronal membrane properties. J. Neurophysiol. 102:974-978.
65. Donnelly-Roberts DL, Jarvis MF. 2007. Discovery of P2X7 receptorselective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br. J. Pharmacol. 151:571-579.
66. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR. 2001. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587-600.
67. Evans RJ, Lewis C, Virginio C, Lundstrom K, Buell G, Surprenant A, North RA. 1996. Ionic permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X receptors) expressed in mammalian cells. J. Physiol. 497(Pt 2):413-422.
68. Nakazawa K, Fujimori K, Takanaka A, Inoue K. 1990. An ATP-activated conductance in pheochromocytoma cells and its suppression by extracellular calcium. J. Physiol. 428:257-272.
69. Sakamoto H, Bellalou J, Sebo P, Ladant D. 1992. Bordetella pertussis adenylate cyclase toxin. Structural and functional independence of the catalytic and hemolytic activities. J. Biol. Chem. 267:13598-13602.
70. Masin J, Konopasek I, Svobodova J, Sebo P. 2004. Different structural requirements for adenylate cyclase toxin interactions with erythrocyte and liposome membranes. Biochim. Biophys. Acta 1660:144-154.
71. Rogel A, Meller R, Hanski E. 1991. Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis. J. Biol. Chem. 266:3154-3161.
72. El-Azami-El-Idrissi M, Bauche C, Loucka J, Osicka R, Sebo P, Ladant D, Leclerc C. 2003. Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: role of toxin acylation and identification of the main integrin interaction domain. J. Biol. Chem. 278:38514-38521.
73. Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, Ladant D, Leclerc C. 2001. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J. Exp. Med. 193:1035-1044.
74. Confer DL, Eaton JW. 1982. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217:948-950.
75. Khelef N, Guiso N. 1995. Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin. FEMS Microbiol. Lett. 134:27-32.
76. Khelef N, Zychlinsky A, Guiso N. 1993. Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect. Immun. 61:4064-4071.
77. Njamkepo E, Pinot F, Francois D, Guiso N, Polla BS, Bachelet M. 2000. Adaptive responses of human monocytes infected by Bordetella pertussis: the role of adenylate cyclase hemolysin. J. Cell. Physiol. 183:91-99.
78. Weingart CL, Weiss AA. 2000. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect. Immun. 68:1735-1739.
79. Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH. 2010. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J. Immunol. 185:1711-1719.